Showing results (61-70 of 180) with videos related to

Sort By:
Pageof 18
Infectious Disease Clinics of North America|February 4, 2020
Collaborative Antimicrobial Stewardship for SurgeonsEvan D Robinson, David F Volles, Katherine Kramme, et al.
Open Forum Infectious Diseases|May 2, 2019
Clinical Yield of a Molecular Diagnostic Panel for Enteric Pathogens in Adult Outpatients With Diarrhea and Validation of Guidelines-Based Criteria for TestingStephen D Clark, Michael Sidlak, Amy J Mathers, et al.
Der Urologe. Ausg. A|November 11, 2009
[Long-term follow-up of the defunctionalized bladder after urinary diversion]F-C von Rundstedt, D Lazica, A S Brandt, et al.
Der Urologe. Ausg. A|October 1, 2008
[Treatment of specific complications of locally advanced prostate cancer]F C von Rundstedt, A S Brandt, D Lazica, et al.
Open Forum Infectious Diseases|May 1, 2023
Successful Treatment of Persistent Stenotrophomonas maltophilia Bacteremia With Cefiderocol in an InfantAlice J Hsu, Patricia J Simner, Yehudit Bergman, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 9, 2016
A single-center experience with infections due to daptomycin-nonsusceptible Enterococcus faecium in liver transplant recipientsJ D Lewis, K B Enfield, H L Cox, et al.
European Urology|October 24, 2003
Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical "Aging Male" symptoms? Results of the "Cologne Male Survey"M H Braun, F Sommer, G Haupt, et al.
Urologia Internationalis|August 31, 2013
Second transurethral resection after Ta high-grade bladder tumor: a 4.5-year period at a single university centerDavid A Lazica, Stephan Roth, Alexander S Brandt, et al.
Microbiology Spectrum|March 6, 2023
Fosfomycin Disk Diffusion Testing among Klebsiella pneumoniae Results in Frequent Inner Colonies and Categorical Disagreement Based on Conflicting Breakpoint Organization RecommendationsMorgan L Bixby, Jenna M Salay, Amanda R Krueger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2022
Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against EnterobacteralesPranita D Tamma, Patrick N A Harris, Amy J Mathers, et al.
Pageof 18